Dale L. Morris

2.3k total citations
44 papers, 1.8k citations indexed

About

Dale L. Morris is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Dale L. Morris has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Dale L. Morris's work include Immunotoxicology and immune responses (12 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Dale L. Morris is often cited by papers focused on Immunotoxicology and immune responses (12 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Dale L. Morris collaborates with scholars based in United States, South Korea and India. Dale L. Morris's co-authors include Michael P. Holsapple, John E. Sagartz, Jeffrey A. Kramer, Neil K. Snyder, Steven C. Wood, Thomas L. Rothstein, Julio C. Dávila, Mollisa M. Elrick, Carl L. Alden and Roderick T. Bunch and has published in prestigious journals such as The Journal of Experimental Medicine, Nature Reviews Drug Discovery and Annals of Neurology.

In The Last Decade

Dale L. Morris

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dale L. Morris United States 20 548 364 302 273 259 44 1.8k
Ning Qu Japan 21 502 0.9× 675 1.9× 128 0.4× 265 1.0× 35 0.1× 108 2.1k
Jerry F. Hardisty United States 23 259 0.5× 421 1.2× 287 1.0× 194 0.7× 118 0.5× 67 1.5k
Ai Sato Japan 25 182 0.3× 554 1.5× 145 0.5× 535 2.0× 61 0.2× 163 2.3k
Janja Marc Slovenia 30 208 0.4× 1.6k 4.3× 111 0.4× 646 2.4× 117 0.5× 145 3.2k
Weifeng Tang China 26 435 0.8× 1.0k 2.8× 183 0.6× 493 1.8× 65 0.3× 169 2.5k
Lian Ma China 24 199 0.4× 669 1.8× 65 0.2× 221 0.8× 139 0.5× 101 1.8k
Carine Chavey France 20 415 0.8× 1.2k 3.3× 220 0.7× 759 2.8× 38 0.1× 29 2.7k
Sunil Nagpal United States 19 237 0.4× 544 1.5× 45 0.1× 253 0.9× 38 0.1× 29 2.1k
Koichi Yoshimura Japan 34 735 1.3× 838 2.3× 99 0.3× 154 0.6× 32 0.1× 125 3.9k
Kevin Gerrish United States 25 210 0.4× 774 2.1× 173 0.6× 146 0.5× 89 0.3× 74 2.0k

Countries citing papers authored by Dale L. Morris

Since Specialization
Citations

This map shows the geographic impact of Dale L. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale L. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale L. Morris more than expected).

Fields of papers citing papers by Dale L. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale L. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale L. Morris. The network helps show where Dale L. Morris may publish in the future.

Co-authorship network of co-authors of Dale L. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Dale L. Morris. A scholar is included among the top collaborators of Dale L. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale L. Morris. Dale L. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Debra M., Michael I. Jesson, Xiong Li, et al.. (2010). Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis. Journal of Inflammation. 7(1). 41–41. 384 indexed citations
2.
Kramer, Jeffrey A., John E. Sagartz, & Dale L. Morris. (2007). The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nature Reviews Drug Discovery. 6(8). 636–649. 241 indexed citations
3.
4.
Dávila, Julio C. & Dale L. Morris. (1999). Analysis of cytochrome P450 and phase II conjugating enzyme expression in adult male rat hepatocytes. In Vitro Cellular & Developmental Biology - Animal. 35(3). 120–130. 27 indexed citations
5.
Morris, Dale L., et al.. (1998). Characterization of the effects of 2,3,7,8-tetrachlorodibenzo- p -dioxin in B6C3F1 and DBA/2 mice following single and repeated exposures. Archives of Toxicology. 72(3). 157–168. 10 indexed citations
6.
Degitz, Sigmund J., et al.. (1998). Role of TGF-β in RA-induced cleft palate in CD-1 mice. Teratology. 58(5). 197–204. 32 indexed citations
7.
Oshiro, Y., et al.. (1998). Exploration of the Transformation Potential of a Unique Male Rat Protein Alpha2u-Globulin Using Hamster Embryonic Cells. Toxicologic Pathology. 26(3). 381–387. 3 indexed citations
8.
Morris, Dale L. & Wendy Komocsar. (1997). Immunophenotyping analysis of peripheral blood, splenic, and thymic lymphocytes in male and female rats. Journal of Pharmacological and Toxicological Methods. 37(1). 37–46. 32 indexed citations
9.
10.
Oshiro, Y. & Dale L. Morris. (1997). TNF-α release from human peripheral blood mononuclear cells to predict the proinflammatory activity of cytokines and growth factors. Journal of Pharmacological and Toxicological Methods. 37(1). 55–59. 10 indexed citations
11.
Karras, James G., et al.. (1996). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Elevates Basal B-Cell Intracellular Calcium Concentration and Suppresses Surface Ig- but Not CD40-Induced Antibody Secretion. Toxicology and Applied Pharmacology. 137(2). 275–284. 24 indexed citations
12.
Morris, Dale L. & Julio C. Dávila. (1996). Analysis of rat cytochrome P450 isoenzyme expression using semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Biochemical Pharmacology. 52(5). 781–792. 74 indexed citations
13.
Wang, Zihua, Dale L. Morris, & Thomas L. Rothstein. (1995). Constitutive and Inducible Levels of egr-1 and c-myc Early Growth Response Gene Expression in Self-Renewing B-1 Lymphocytes. Cellular Immunology. 162(2). 309–314. 9 indexed citations
14.
Morris, Dale L., James G. Karras, & Michael P. Holsapple. (1993). Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells. Immunopharmacology. 26(2). 105–112. 25 indexed citations
15.
Holsapple, Michael P., et al.. (1991). Role of ah receptor in suppression of in vivo antibody response by 2 3 7 8 tetrachlorodibenzo p dioxin tcdd is dependent on exposure conditions. The FASEB Journal. 5(4). 508. 1 indexed citations
16.
Holsapple, Michael P., Neil K. Snyder, Steven C. Wood, & Dale L. Morris. (1991). A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology. 69(3). 219–255. 177 indexed citations
17.
Adams, Michael L., Dale L. Morris, David A. Brase, & William L. Dewey. (1991). Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs. Life Sciences. 48(9). 917–924. 13 indexed citations
18.
Zimmerman, R. S., Ronald L. Hayes, Dale L. Morris, et al.. (1990). Beta-endorphin in cerebrospinal fluid and serum after severe head injury. Neurosurgery. 26(5). 764–764. 14 indexed citations
19.
20.
Myer, Edwin C., Dale L. Morris, Michael L. Adams, David A. Brase, & William L. Dewey. (1987). Increased cerebrospinal fluid β-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome. The Journal of Pediatrics. 111(5). 660–666. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ning Qu Breakdown of academic impact, for papers by Jerry F. Hardisty Breakdown of academic impact, for papers by Ai Sato Breakdown of academic impact, for papers by Janja Marc Breakdown of academic impact, for papers by Weifeng Tang Breakdown of academic impact, for papers by Lian Ma Breakdown of academic impact, for papers by Carine Chavey Breakdown of academic impact, for papers by Sunil Nagpal Breakdown of academic impact, for papers by Koichi Yoshimura Breakdown of academic impact, for papers by Kevin Gerrish
Rankless by CCL
2026